Sun CH, Zheng W, Yang XH, Cai DB, Ng CH, Ungvari GS, et al
GSH augmentation as a potential therapeutic strategy in CNS disease has been suggested for decades, 23 although repletion efforts have been hindered by inability to assess human CNS GSH concentrations in vivo and poor oral absorption of GSH
6.3 Advancing precision medicine The heterogeneity of PD underscores the need for personalized therapy
Follow-Up Sessions To maintain and enhance the whitening effects, a series of follow-up sessions is usually recommended
Summary: GLP-1 headaches typically resolve with adequate hydration, over-the-counter painkillers like paracetamol, rest, and maintaining regular small meals during the initial treatment adjustment period
Researchers concluded, Our main finding is that prescribed semaglutide is associated with an increased risk of NAION. Diabetic patients who took semaglutide were more than four times more likely to develop NAION than those on non-GLP-1 medications